Respiratory Syncytial Virus: the Possible Trigger of Airway Remodeling Through Matrix Metalloproteinase Activation?
Fuqiang Wen,Daishun Liu
DOI: https://doi.org/10.1097/00029330-200701010-00001
2007-01-01
Abstract:Respiratory syncytial virus (RSV) is a leading cause of epidemic respiratory tract illness in children. Severe RSV infections involving the lower respiratory tract are primarily seen in young children with naive immune systems and/or genetic predispositions. However, RSV was not recognized as a potentially serious problem in older adults until the 1970s, when outbreaks of the virus infection occurred in long-term care facilities. Since then, additional studies in hospitalized adults have suggested that RSV may be an important cause of illness in community-dwelling elderly people, patients with suppressed T-cell immunity (such as heart transplant recipients).1 RSV is now increasingly recognized as an important pathogen in adults with cardiopulmonary disease. Recently Falsey et al2 reported that most RSV infections in patients with chronic obstructive pulmonary disease (COPD) are associated with symptomatic respiratory illnesses and measurable immune responses. In studies of COPD exacerbation, RSV has been identified with variable frequency ranging from 0.8% to 22% depending on the diagnostic methods used. A possible linkage between RSV infection and asthma has been proposed in early childhood and subsequent manifestations of atopy and persistent asthma. Prototypical of these, Sigurs et al3 followed a population of children after hospitalization for RSV bronchiolitis during infancy, together with matched uninfected controls, and reported a 3.5-fold excess in allergy and a 10-fold excess of asthma in the post-infected population 3 years later. It was particularly interesting that risk for asthma development after RSV infection was much higher in children with a positive family history (and hence at high genetic risk) of allergy. Airway epithelium plays a central role in initiating pulmonary inflammation, particularly in the case of RSV, since this virus productively replicates only in the respiratory mucosa. A typical pattern of inflammation accompanies RSV bronchiolitis, which includes epithelial sloughing in the small airways accompanied by hypersecretion of mucus and edema, resulting in extensive hyperinflation, airflow obstruction, and cough and wheeze.4 In relation to asthma, one of the mechanisms posits indirect stimulation of the disease process via promotion of sensitization to inhalant allergens, as a result of the intrinsically “Th2-trophic” effects of the virus. Later studies5 indicate that development of long-term T cell memory specific for these allergens typically occurs during early childhood, bracketing the period during which RSV infection is most frequent. The process that bystander stimulation of ongoing T cell responses to inhalant allergens by intermittent RSV infections, through the triggering of local Th2 cytokine production in the airway mucosa,6 may tip the balance toward consolidation of Th2-polarized memory against the allergens, thus setting the scene for subsequent atopic asthma. In addition to these manifestations of direct epithelial involvement, RSV infection produces a pronounced perivascular infiltrate of mononuclear cells and lymphocytes and a neutrophil-rich exudate detected by bronchoalveolar lavage (BAL). RSV is demonstrated to induce airway epithelium to secrete interleukins, growth factors, cytokines, and chemokines in vitro and in vivo.7 The CC chemokines, a subgroup of chemokines have an important role in recruiting leukocytes to areas of infection. Excessive release of CC chemokines at the time of RSV infection may cause severe inflammation and have an equally important role in RSV disease pathogenesis as Th2-type cytokines. Moreover, studies in infected adults indicate that tissue repair is apparent within days after the onset of symptoms, but restoration of ciliated airway epithelial cells takes several weeks, a period during which symptoms of cough, wheeze, and altered lung function commonly persist.8 Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that have a number of important physiological roles including remodeling of the extracellular matrix, facilitating cell migration, cleaving cytokines, and activating defensins. But excess MMP activity may lead to tissue destruction. MMP expression in inflammatory and stromal cells is up-regulated by exogenous stimuli, cytokines, and down-regulated by interferon (IFN)-γ and Th2-type cytokine (IL-4 and IL-10). Clinical studies and animal models show that excess MMP activity causes matrix breakdown in patients with COPD, acute respiratory distress syndrome, sarcoidosis, and tuberculosis.9 In a mouse model of allergen-induced airway remodeling, Lim et al10 found that ovalbumin (OVA)-challenged MMP-9-deficient mice had less peribronchial fibrosis and total lung collagen, and had reduced levels of BAL regulated on activation, normal T cell expressed, and secreted RANTES, as well as reduced numbers of BAL and peribronchial eosinophils when compared with OVA-challenged wild type mice. Lim's study demonstrates that MMP-9 may play a role in mediating selected aspects of allergen-induced airway remodeling. Although Yeo et al11 reported that RSV infection induces MMP-9 expression in cultured epithelial cells, a more comprehensive examination of the pattern of tissue remodeling possibly triggered by RSV-infected lung model has not been performed. In this issue of the Journal, Li et al12 found that in mice infected with RSV can significantly increase the activity of MMP-9 and MMP-2. The RSV infection can increase the activity of gelatinase and simultaneously up-regulate its inhibitory factors but increase its protein ratio of MMP-9/TIMP-1 in lung tissues. Those data suggest that RSV infection may result in the increase of MMP activity and trigger lung remodeling despite the lacking of either the route or the mediator of MMP activation. Although it still needs further data to elucidate the localization of MMP-9 activation in situ, the recent publications together with Li's in the current issue suggest the important therapeutic target for viral infected inflammatory airway disease.